News Powered By AI

No Advertisment | Contact Us  |  Publish
  • RN Home
  • About RocketNews
    • About RocketNews
    • Article Submission Form
    • Commercial News Posting and Writing Services
    • Contact RocketNews
  • News Categories
    • Business
    • Climate Change
    • Education
    • Energy
    • Entertainment
    • Financial
    • Health
    • Jobs
    • Politics
    • Religion
    • Science
    • Sports
    • Stock Market News
    • Technology
    • Top Stories
    • Travel
    • World
No Advertisment | Contact Us  |  Publish
  • RN Home
  • About RocketNews
    • About RocketNews
    • Article Submission Form
    • Commercial News Posting and Writing Services
    • Contact RocketNews
  • News Categories
    • Business
    • Climate Change
    • Education
    • Energy
    • Entertainment
    • Financial
    • Health
    • Jobs
    • Politics
    • Religion
    • Science
    • Sports
    • Stock Market News
    • Technology
    • Top Stories
    • Travel
    • World

News Powered By AI

First pill to prevent COVID-19 after exposure approved by FDA – kare11.com

by News Feed Editor | Jun 1, 2026 | COVID-19

First pill to prevent COVID-19 after exposure approved by FDA  kare11.com Article Attribution | Read More at Article Source

FDA Approves Oral Antiviral to Prevent COVID-19 After Exposure – MedPage Today

by News Feed Editor | Jun 1, 2026 | COVID-19

FDA Approves Oral Antiviral to Prevent COVID-19 After Exposure  MedPage Today Article Attribution | Read More at Article Source

Shionogi’s COVID antiviral Xocova passes muster with FDA as post-exposure preventative – Fierce Pharma

by News Feed Editor | Jun 1, 2026 | COVID-19

Shionogi’s COVID antiviral Xocova passes muster with FDA as post-exposure preventative  Fierce Pharma Article Attribution | Read More at Article Source

US regulator approves oral drug from Japan’s Shionogi to prevent COVID-19 – Reuters

by News Feed Editor | Jun 1, 2026 | COVID-19

US regulator approves oral drug from Japan’s Shionogi to prevent COVID-19  Reuters Article Attribution | Read More at Article Source

FDA Approves Ensitrelvir as First Oral Post-Exposure Prevention Option for COVID-19 – Contagion Live

by News Feed Editor | Jun 1, 2026 | COVID-19

FDA Approves Ensitrelvir as First Oral Post-Exposure Prevention Option for COVID-19  Contagion Live Article Attribution | Read More at Article Source

FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 – Drug Topics

by News Feed Editor | Jun 1, 2026 | COVID-19

FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19  Drug Topics Article Attribution | Read More at Article Source
« Older Entries
Next Entries »

Recent Posts

  • US adds 175,000 April jobs as hiring slows and unemployment stays steady
  • US job market grows amid threats of mass federal layoffs and Trump tariffs
  • US lost 105,000 jobs in October and added 64,000 in November, according to delayed data
  • Writing skills are getting more attention in school
  • Paying vendors for student results

Recent Comments

No comments to show.

About RN

RocketNews is a news aggregator covering top stories from around the globe across 17 categories. Stories are gathered from leading news organizations — including the BBC, The Guardian, the Associated Press, NPR, Al Jazeera, and respected industry publications — along with government sources and official releases. Each story is presented without advertising as an original summary produced with Claude AI, with attribution and a link to the original reporting at the source. RocketNews also publishes featured articles from contributing writers. Story selection and summaries are automated.

Website Awards

2004 Webby Award Nomination

RocketNews nominated for a Webby Award

Search Engine Watch past honorable mention winner for Best News Search Engine.

More Info

About RocketNews

Contact RocketNews

Definitions and Terms

Privacy Policy

Site Design and Operation by Murray Owen LLC | A Web Development and Operations Company